{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T05:58:03Z","timestamp":1698040683412},"reference-count":17,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":9795,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1985,10]]},"abstract":"<jats:p>The pharmacokinetics of antipyrine have been studied in patients with schistosomiasis. In comparison to a control group of subjects (n = 6), patients with early (active) schistosomiasis (passing live ova in urine or stools without clinical and laboratory evidence of liver involvement; n = 6) exhibited similar pharmacokinetic parameters. Of seven patients with hepatosplenic schistosomiasis (exhibiting hepatic fibrosis, splenomegaly, at least one episode of haematemesis, ascites), five showed markedly enhanced antipyrine half\u2010life and reduced clearance. Compared to controls, the mean half\u2010life of this group was increased from 10.9 +\/\u2010 2.4 to 19.9 +\/\u2010 9.5 h (mean +\/\u2010 s.d.; P less than or equal to 0.05) and clearance reduced from 3.81 +\/\u2010 0.74 to 2.18 +\/\u2010 0.80 l h\u20101 (P less than or equal to 0.01). There was no change in the apparent volume of distribution. Liver biopsy was performed on all patients diagnosed as having hepatosplenic schistosomiasis in the 2 weeks prior to the antipyrine study. The results of this study indicate that hepatic microsomal metabolism is impaired in patients with advanced hepatosplenic schistosomiasis.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1985.tb05069.x","type":"journal-article","created":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T21:48:33Z","timestamp":1343339313000},"page":"313-316","source":"Crossref","is-referenced-by-count":13,"title":["The pharmacokinetics of antipyrine in patients with graded severity of schistosomiasis."],"prefix":"10.1111","volume":"20","author":[{"given":"I.","family":"el\u2010Raghy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DJ","family":"Back","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MA","family":"Nafeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ML","family":"Orme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4049\/jimmunol.123.4.1829","article-title":"Histocompatability\u2010linked susceptibility for hepatosplenomegaly in human schistosomiasis mansoni","volume":"123","author":"Salem E. Abdel","year":"1979","journal-title":"J. Immunol."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb02206.x"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197702010-00003"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.14.7.569"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197601040-00002"},{"key":"e_1_2_1_7_1","first-page":"254","article-title":"Altered drug metabolism in hepatosplenic schistosomiasis","volume":"21","author":"Brant P. C.","year":"1979","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"e_1_2_1_8_1","first-page":"432","article-title":"Effect of Schistosoma Mansoni infection on the hepatic drug metabolising capacity of mice","volume":"199","author":"Cha Y. N.","year":"1976","journal-title":"J. Pharmac. exp. Ther."},{"key":"e_1_2_1_9_1","first-page":"611P","article-title":"The pharmacokinetics of oxamniquine in advanced hepatosplenic schistosomiasis in the Sudan","volume":"15","author":"Daneshmend T. K.","year":"1983","journal-title":"Br. J. clin. Pharmac."},{"key":"e_1_2_1_10_1","first-page":"152","article-title":"The effect of hepatosplenic schistosomiasis on the pharmacokinetics of metronidazole and labetalol","volume":"14","author":"Danesmend T. K.","year":"1982","journal-title":"Br. J. clin. Pharmac."},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.133"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010615"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.19.9.808"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)34736-5"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198005030-00005"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602537808993788"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/03602537508993754"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198005060-00002"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1985.tb05069.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1985.tb05069.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T20:01:41Z","timestamp":1697832101000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1985.tb05069.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1985,10]]}},"alternative-id":["10.1111\/j.1365-2125.1985.tb05069.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1985.tb05069.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,10]]}}}